127 related articles for article (PubMed ID: 9642436)
1. Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies.
Bronsky EA; Falliers CJ; Kaiser HB; Ahlbrandt R; Mason JM
Allergy Asthma Proc; 1998; 19(3):135-41. PubMed ID: 9642436
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
Casale TB; Andrade C; Qu R
Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
Van Cauwenberge P; Juniper EF
Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL; Mason J; Compton D; Stewart J; Ricard N
J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
[TBL] [Abstract][Full Text] [Related]
8. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular safety of fexofenadine HCl.
Pratt CM; Mason J; Russell T; Reynolds R; Ahlbrandt R
Am J Cardiol; 1999 May; 83(10):1451-4. PubMed ID: 10335761
[TBL] [Abstract][Full Text] [Related]
10. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
12. Fexofenadine.
Markham A; Wagstaff AJ
Drugs; 1998 Feb; 55(2):269-74; discussion 275-6. PubMed ID: 9506246
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
15. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Nelson HS; Reynolds R; Mason J
Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
[TBL] [Abstract][Full Text] [Related]
16. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
18. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
Compalati E; Baena-Cagnani R; Penagos M; Badellino H; Braido F; Gómez RM; Canonica GW; Baena-Cagnani CE
Int Arch Allergy Immunol; 2011; 156(1):1-15. PubMed ID: 21969990
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
Prenner BM; Capano D; Harris AG
Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular safety of fexofenadine HCl.
Pratt C; Brown AM; Rampe D; Mason J; Russell T; Reynolds R; Ahlbrandt R
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():212-6. PubMed ID: 10444240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
